Observations and recommendations for community-based diabetes screenings

Diabetes Educator

Volumn 36, Issue 6, 2010, Pages 887-893

  West, Brian ^a   Parikh, Punam ^c   Arniella, Guedy ^b   Horowitz, Carol R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MASS SCREENING; METHODOLOGY; PATIENT CARE; STANDARD; UNITED STATES;

CONTINUITY OF PATIENT CARE; DIABETES MELLITUS; HEALTH CARE COALITIONS; HUMANS; MASS SCREENING; NEW YORK CITY; PREDIABETIC STATE; PROGRAM EVALUATION; QUALITY OF HEALTH CARE; REFERENCE STANDARDS;

EID: 78650156212     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721710386973     Document Type: Article

References (26)

1. Cowie CC, Rust KF, Ford ES,et al.Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32:287-294.
2. Cowie CC, Rust KF, Byrd-Holt DD,et al.Prevalence of diabetes and impaired fasting glucose in adults in the US population: National Health and Nutrition Survey 1999-2002. Diabetes Care. 2006;29:1263-1268.
3. Zhang Q., Wang Y., Huang ES Changes in racial/ethnic disparities in the prevalence of type 2 diabetes by obesity level among US adults. Ethn Health. 2009:14:1-19.
4. American Diabetes Association position statement screening for type 2 diabetes. Diabetes Care. 2004;27(suppl 1):S11-S14.
5. Tuomilehto J., Lindstrom J., Eriksson JG,et al.Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
6. Gaede P., Vedel P., Nicolai L.,et al.Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
7. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
8. Heine RJ, Diamant M., Mbanya JC,et al.Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure? BMJ. 2006;333:1200-1204.
9. Grant T., Soriano Y., Marantz PR,et al.Community-based screening for cardiovascular disease and diabetes using HbA1c. Am J Prev Med. 2004:26:271-275.
10. Tabaei BP, Burke R., Constance A.,et al.Community-based screening for diabetes in Michigan. Diabetes Care. 2003:26:668-670.
11. Newman WP, Nelson R., Scheer K. Community screening for diabetes: low detection rate in a low-risk population. Diabetes Care. 1994:17:363-365.
12. O'Connor PJ, Rush WA, Cherney LM,et al.Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability. Eff Clin Pract. 2001;4:271-277.
13. Strychar I., Yale JF, Aris-Jilwan N.,et al.Follow-up behaviors of individuals who attended a community-based diabetes screening program. Can J Diabetes. 2004:28:1-9.
14. Lanza A., Albright A., Zucker H.,et al.The Diabetes Detection Initiative: a pilot program of selective screening. Am J Health Behav. 2007:31:632-642.
15. Kim M., Berger D., Matte T. Diabetes in New York City: Public Health Burden and Disparities. New York, NY: New York City Department of Health and Mental Hygiene; 2006.
16. Bergenstal RM Evaluating the accuracy of modern glucose meters. Insulin. 2008;3(1):5-14.
17. Stein C. The effects of two differing techniques on the accuracy of reagent strip blood glucose testing. Health SA Gesondheid. 2007; 12(3):17-25.
18. International Organization for Standardization. ISO 15197 In Vitro Diagnostic Test Systems: Requirements for Blood-Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus. Geneva, Switzerland: International Organization for Standardization; 2003.
19. American Diabetes Association. Standards of medical care in diabetes: 2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
20. Edelman D., Olsen MK, Dudley TK,et al.Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med. 2004;19:1175-1180.
21. Rohlfing CL, Little RR, Wiedmeyer H.,et al.Use of GHb (HbA1c) in screening for undiagnosed diabetes in the US population. Diabetes Care. 2000; 23(2):187-191.
22. Schwartz KL, Monsur J., Hammad A.,et al.Comparison of point of care and laboratory HbA1c analysis: a MetroNet study. J Am Board Fam Med. 2009;22:461-463.
23. Sicard DA, Taylor JR Comparison of point-of-care HbA1c test versus standardized laboratory testing. Ann Pharmacother. 2005;39:1024-1028.
24. Hawkins RC Comparison of four point-of-care HbA1c analytical systems against central laboratory analysis. Singapore Med J. 2003; 44:8-11.
25. Bode BW, Irwin BR, Pierce JA,et al.Advances in hemoglobin A1c point of care technology. J Diabetes Sci Technol. 2007;1:405-411.
26. Horowitz CR, Robinson M., Seifer S. Community-based participatory research's journey from margins to mainstream: are researchers prepared? Circulation. 2009;119;2633-2642.